Neoleukin: Q2 Earnings Snapshot

SEATTLE (AP) _ Neoleukin Therapeutics, Inc. (NLTX) on Tuesday reported a loss of $15.7 million in its second quarter.

On a per-share basis, the Seattle-based company said it had a loss of 28 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NLTX at https://www.zacks.com/ap/NLTX